Nonsecretory Multiple Myeloma: New Options in Assessment and Treatment

Nonsecretory Multiple Myeloma: New Options in Assessment and Treatment

Hallmark of most multiple myeloma cases is the persistent production of some form of immunoglobulins, a phenomenon that brings the disease to attention. However, there is a subset of multiple myeloma patients who do not secrete immunoglobulin or its component parts into either the blood or urine, hence called non-secretory myeloma. Some non-secretory myeloma patients may produce the immunoglobulin proteins but they have defects in secretion. Due to lack of these protein biomarkers in blood and urine, it may be difficult to assess and treat the disease. Our myeloma panel is talking to Dr. Frits Van Rhee about latest developments and new options available in assessment and treatment of nonsecretory myeloma.

Panelists

Talk Recorded on March 27, 2017, 5 p.m.   EST 169 3

Hear Talk Audio




  • CMC March 27, 2017, 5:11 p.m.  US/Eastern

    Is non-secretory Myeloma often Light Chain Myeloma or can there be other types of myeloma as well?

  • Anonymous User March 27, 2017, 4:51 p.m.  US/Eastern

    Is there a particular combination of therapies that seems to work best in Non-secretory myeloma patients?

  • Anonymous User March 21, 2017, 11:11 p.m.  US/Eastern

    I am in Remission and have regular blood tests. Are they relevant? Or are only portions relevant? Have they been a waste of time and money?